Anonymous
Guest
Anonymous
Guest
Little tier 3 for Hysingla ER trust me!! Mostly failure of a couple other meds first.
Little tier 3 for Hysingla ER trust me!! Mostly failure of a couple other meds first.
Go to the Purdue board and see how much they're moaning about lack of Hysingla coverage. Stop thinking about the competition.
So...your argument is 2 idiotic wrongs make Zogenix somehow a little more right? Nice argument. Clearly you give yourself away. I have only one guess who this post is from...
Rhymes with Chimpanzee.
Trx count for $1000 Alex.
60 days....
Um...How long will it take for Hysingla to eat up all Zohydro scripts?
Alex...
the results are coming in...even top performers in the first two weeks of post launch Hysingla are showing reductions in the 50% range.
May I amend my answer to 45 days?
I hope my bonus check hits. And Roger's too - he deserves that 2.5M yacht for a few more months to help him pretend he belongs at the executive level. Ass clown.
Look, I'm double dipping here, so if this job doesn't work for me, not a big deal (Don't waste your time replying they will figure me out, they won't. No one has for 6 years, so bite me). Here, though, are my predictions for this job. You will argu them, but in 12 months come back to this post cause I'll be right on.
1) Sold in 12 months. There are people who were brought to this company that specialize in just this, trying to get a big pharma company to buy. Take a look and you'll figure out quick who they are and what companies they were with, and their inevitable outcome. It's true.
2) Mass layoffs. With all the bad press about Zohydro, states trying to stop its approval, the risk of another Oxy, C3's that are easier and cheaper to write, this product will have little to no coverage. It will be a tough sell, even for your buddy docs who carried you at other jobs. Plus, the S Pen sucks. About 50% of the time it bruises the skin and doesn't inject properly. Neuro's hate it. It's got about as much business as it will ever get.
3) Zogenix is a block buster!!! LOL, just kidding! See prediction 1 or 2.
The idea is great, and we all have docs who are excited about Zohydro. But the truth is coverage will be painfully tough. Read the articles online. The states, the national government and the communities don't want this. If you take it for what it is (a paycheck for a year) you will be fine. If you think you are going to cash in the stock and retire in 4 years, you are an idiot. Good luck.
Genius.
Go to the Purdue board and see how much they're moaning about lack of Hysingla coverage. Stop thinking about the competition.
Ill grant you that you were correct but don't break your arm patting yourself on the back. Nobody likes a person that returns to say "I told you so".